CVJan 23, 2018

DeepGestalt - Identifying Rare Genetic Syndromes Using Deep Learning

arXiv:1801.07637v135 citations
Originality Incremental advance
AI Analysis

This addresses the challenge of diagnosing hundreds of genetic syndromes in clinical settings, potentially supporting medical genetics and precision medicine, though it builds incrementally on existing facial analysis technologies.

The researchers tackled the problem of identifying rare genetic syndromes from facial images, developing DeepGestalt, a deep learning framework that achieved 91% top-10 accuracy in identifying over 215 syndromes and outperformed clinical experts in experiments.

Facial analysis technologies have recently measured up to the capabilities of expert clinicians in syndrome identification. To date, these technologies could only identify phenotypes of a few diseases, limiting their role in clinical settings where hundreds of diagnoses must be considered. We developed a facial analysis framework, DeepGestalt, using computer vision and deep learning algorithms, that quantifies similarities to hundreds of genetic syndromes based on unconstrained 2D images. DeepGestalt is currently trained with over 26,000 patient cases from a rapidly growing phenotype-genotype database, consisting of tens of thousands of validated clinical cases, curated through a community-driven platform. DeepGestalt currently achieves 91% top-10-accuracy in identifying over 215 different genetic syndromes and has outperformed clinical experts in three separate experiments. We suggest that this form of artificial intelligence is ready to support medical genetics in clinical and laboratory practices and will play a key role in the future of precision medicine.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes